Zeus Sleep has secured a grant from the National Institute for Health and Care Research (NIHR) to fund one of the largest trials for OSA in UK history.

A rival re-emerges, investors brace for impact and the Ozempic scare dissolves. ResMed’s growth story just got more interesting. ... Read More The post Dr Boreham’s Crucible: A rival may be circling, ...

Columnist Ben Hofmeister has just completed his third overnight sleep study in three years as part of an effort to control sleep apnea.

If you have been struggling with sleep apnea for a while now, then you undeniably understand that this sleep disorder can affect the overall quality of your day. It disrupts... The post What Is Oral ...

Dr Xand van Tulleken, the resident doctor regularly appearing on BBC's Morning Live, claimed that millions could have sleep apnoea and not even know it. However, there are ways to get the evidence you ...

Teeth grinding isn’t just a dental problem. It may also speed up aging. Research shows that people who grind their teeth ...

In a key post-recall milestone, Philips says it has more than doubled its number of 510(k) clearances from the U.S. Food and Drug Administration (FDA) over the past two years.

ResMed Inc. (NYSE:RMD) is one of the best medical technology stocks to invest in. On January 30, KeyBanc Capital Markets lifted its price target on ResMed Inc. (NYSE:RMD) to $302 from $299 and ...

Around eight million people in the UK might have this issue, but only a small number have been diagnosed ...

ACHES, pains, creaks and stiffness… chances are you fob it all off as an inevitable part of ‘getting older’. But, doctors don’t consider any pain normal… there’s always a ...

Do either of these ASX 200 companies appeal to you? The post Bargain buys! – Scoop up these ASX 200 stocks after yesterday's crash appeared first on The Motley Fool Australia.

Medical technology, or MedTech, companies ensure that the broader healthcare industry has the tools needed to diagnose, treat, monitor, or prevent medical conditions.